“…If both tests are normal, screening can be reduced to an annual schedule (Kaplan et al, 2009). Despite guidelines aimed to decrease the heavy burden of cervical cancer among HIV-infected women, Papanicolaou (Pap) screening is still underutilized by this population of women (Baranoski, Horsburgh, Cupples, Aschengrau, & Stier, 2011; Fletcher et al, 2013; Keiser et al, 2006; Logan, Khambaty, D'Souza, & Menezes, 2010; Oster, Sullivan, & Blair, 2009; Tello et al, 2010). However, a consensus is lacking on the most important barriers to cervical cancer screening utilization among HIV-infected women.…”